GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
Comment: JSF-3285 is an indazole antibacterial compound discovered using a structure-based approach to optimize DG167 (PubChem CID 70689295), a known inhibitor of Mycobacterium tuberculosis 3-oxoacyl-[acyl-carrier-protein] synthase 1 (also known as β-ketoacyl-ACP synthase, KasA) [2]. JSF-3285 is being investigated as a preclinical candidate for the treatment of tuberculosis (TB). The structure is claimed in patent WO2019046467A1 filed by Rutgers University [1].
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| 4-fluoro-N-(3-methyl-1H-indazol-5-yl)butane-1-sulfonamide |
Database Links ![]() |
|
| Specialist databases | |
Antibiotic DB
|
JSF-3285 |
| Other databases | |
| CAS Registry No. | 2293983-99-8 (source: Scifinder) |
| ChEMBL Ligand | CHEMBL5181555 |
| GtoPdb PubChem SID | 504705404 |
| PubChem CID | 137523337 |
| RCSB PDB Ligand | JFX |
| Search Google for chemical match using the InChIKey | AHVAAGWAEHSRBU-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | AHVAAGWAEHSRBU |
| UniChem Compound Search for chemical match using the InChIKey | AHVAAGWAEHSRBU-UHFFFAOYSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | AHVAAGWAEHSRBU-UHFFFAOYSA-N |